Neuquinon


Indications and Reactions:

Role Indications Reactions
Secondary
Adult T-cell Lymphoma/leukaemia 21.3%
Sudden Hearing Loss 17.0%
Drug Use For Unknown Indication 8.5%
Insomnia 8.5%
Hypertension 6.4%
Back Pain 4.3%
Cardiotoxicity 4.3%
Gastric Mucosal Lesion 4.3%
Tinnitus 4.3%
Antibiotic Prophylaxis 2.1%
Benign Prostatic Hyperplasia 2.1%
Cardiac Disorder 2.1%
Cerebral Ischaemia 2.1%
Depression 2.1%
Gastric Disorder 2.1%
Infection Prophylaxis 2.1%
Pneumocystis Jiroveci Pneumonia 2.1%
Supplementation Therapy 2.1%
Tumour Lysis Syndrome 2.1%
Memory Impairment 28.6%
White Blood Cell Count Decreased 28.6%
Leukoencephalopathy 14.3%
Myelodysplastic Syndrome 14.3%
Skin Atrophy 14.3%
Concomitant
Product Used For Unknown Indication 21.3%
Prophylaxis 13.9%
Cardiac Failure Chronic 9.4%
Hypertension 8.9%
Cardiac Failure 5.3%
Diabetes Mellitus 4.5%
Acute Lymphocytic Leukaemia 3.9%
Constipation 3.7%
Insomnia 3.4%
Neoplasm Malignant 3.3%
Infection Prophylaxis 3.2%
Gastritis 2.7%
Atrial Fibrillation 2.6%
Cardiac Failure Congestive 2.4%
Adult T-cell Lymphoma/leukaemia 2.2%
Rheumatoid Arthritis 2.2%
Febrile Neutropenia 2.1%
Depression 1.7%
Drug Use For Unknown Indication 1.7%
Gastric Ulcer 1.7%
Vomiting 12.0%
Hepatic Function Abnormal 8.4%
Sepsis 6.0%
White Blood Cell Count Decreased 6.0%
Colitis Ischaemic 4.8%
Haemorrhage Subcutaneous 4.8%
Interstitial Lung Disease 4.8%
Pneumonia 4.8%
Pneumonia Aspiration 4.8%
Pyrexia 4.8%
Subdural Haematoma 4.8%
Wheezing 4.8%
Cardiac Failure 3.6%
Death 3.6%
Gamma-glutamyltransferase Increased 3.6%
Hypoglycaemia 3.6%
Lymphocyte Count Decreased 3.6%
Oedema Peripheral 3.6%
Pain In Extremity 3.6%
Platelet Count Decreased 3.6%

Drug Data